The timing of immunotherapy initiation is not a significant factor in the outcomes of patients with extensive-stage small ...

Cancer researchers discovered how exercise really can be like a drug for colon cancer, and AstraZeneca is pioneering new ways to treat early disease.

It sounds too simple to be true. Exercise works just as effectively as a drug to slash the risk of dying from bowel cancer, ...

A recent trial reveals that durvalumab enhances event-free survival in patients with resectable gastric and gastroesophageal junction adenocarcinoma.

The SMC has also has accepted Cladribine, also known as Mavenclad, for the treatment of relapsing-remitting multiple ...

Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is undergoing a significant transformation in ...

Interim results from the global MATTERHORN study mark the first time an immunotherapy has demonstrated statistically ...

Analysts said the data suggest “a strong treatment effect.” Jazz has filed for FDA approval for the combination, which could ...

The ADC market was valued at $8.6bn in 2023, with it forecast to exceed $45bn by 2030, according to analysis by GlobalData.

Three more fake batches of the cancer immunotherapy have been encountered in Iran and Türkiye, warns the agency.